271 related articles for article (PubMed ID: 28988706)
1. Potential role of IL-37 in atherosclerosis.
McCurdy S; Liu CA; Yap J; Boisvert WA
Cytokine; 2019 Oct; 122():154169. PubMed ID: 28988706
[TBL] [Abstract][Full Text] [Related]
2. IL-37-a putative therapeutic agent in cardiovascular diseases.
McCurdy S; Yap J; Irei J; Lozano J; Boisvert WA
QJM; 2022 Nov; 115(11):719-725. PubMed ID: 33486516
[TBL] [Abstract][Full Text] [Related]
3. The family of the interleukin-1 receptors.
Boraschi D; Italiani P; Weil S; Martin MU
Immunol Rev; 2018 Jan; 281(1):197-232. PubMed ID: 29248002
[TBL] [Abstract][Full Text] [Related]
4. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
[TBL] [Abstract][Full Text] [Related]
5. Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability.
Liu J; Lin J; He S; Wu C; Wang B; Liu J; Duan Y; Liu T; Shan S; Yang K; Dong N; Ji Q; Huang K; Li D
Cell Physiol Biochem; 2018; 45(3):1034-1050. PubMed ID: 29439249
[TBL] [Abstract][Full Text] [Related]
6. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
[TBL] [Abstract][Full Text] [Related]
7. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
8. I
Ma L; Qian L; Ying Q; Zhang Y; Zhou C; Wu G
Mol Cell Endocrinol; 2017 Jan; 440():80-92. PubMed ID: 27725191
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of targeting IL-1 and IL-18 in inflammation.
Braddock M; Quinn A; Canvin J
Expert Opin Biol Ther; 2004 Jun; 4(6):847-60. PubMed ID: 15174967
[TBL] [Abstract][Full Text] [Related]
10. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung.
Borthwick LA
Semin Immunopathol; 2016 Jul; 38(4):517-34. PubMed ID: 27001429
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
12. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.
Gieseg SP; Crone EM; Flavall EA; Amit Z
Br J Pharmacol; 2008 Feb; 153(4):627-35. PubMed ID: 17700723
[TBL] [Abstract][Full Text] [Related]
13. Insight into interleukin-37: The potential therapeutic target in allergic diseases.
Huang Z; Xie L; Li H; Liu X; Bellanti JA; Zheng SG; Su W
Cytokine Growth Factor Rev; 2019 Oct; 49():32-41. PubMed ID: 31672283
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-37 in Cardiovascular Disease Inflammation.
Yang Z; Kang L; Wang Y; Xiang J; Wu Q; Xu C; Zhou Y; Chen S; Fang H; Liu J; Dong M
Can J Cardiol; 2019 Jul; 35(7):923-930. PubMed ID: 31292092
[TBL] [Abstract][Full Text] [Related]
15. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function.
Han X; Boisvert WA
Thromb Haemost; 2015 Mar; 113(3):505-12. PubMed ID: 25373619
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets.
Anselmo A; Riva F; Gentile S; Soldani C; Barbagallo M; Mazzon C; Feruglio F; Polentarutti N; Somma P; Carullo P; Angelini C; Bacci M; Mendolicchio GL; Voza A; Nebuloni M; Mantovani A; Garlanda C
Cardiovasc Res; 2016 Sep; 111(4):373-84. PubMed ID: 27297888
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-38 in atherosclerosis.
Zhang XH; Li Y; Zhou L; Tian GP
Clin Chim Acta; 2022 Nov; 536():86-93. PubMed ID: 36150521
[TBL] [Abstract][Full Text] [Related]
19. M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment.
Bi Y; Chen J; Hu F; Liu J; Li M; Zhao L
Neural Plast; 2019; 2019():6724903. PubMed ID: 30923552
[TBL] [Abstract][Full Text] [Related]
20. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
